Cargando…
Cysteine Peptidases as Schistosomiasis Vaccines with Inbuilt Adjuvanticity
Schistosomiasis is caused by several worm species of the genus Schistosoma and afflicts up to 600 million people in 74 tropical and sub-tropical countries in the developing world. Present disease control depends on treatment with the only available drug praziquantel. No vaccine exists despite the in...
Autores principales: | El Ridi, Rashika, Tallima, Hatem, Selim, Sahar, Donnelly, Sheila, Cotton, Sophie, Gonzales Santana, Bibiana, Dalton, John P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897446/ https://www.ncbi.nlm.nih.gov/pubmed/24465551 http://dx.doi.org/10.1371/journal.pone.0085401 |
Ejemplares similares
-
Induction of protective immune responses against schistosomiasis using functionally active cysteine peptidases
por: El Ridi, Rashika, et al.
Publicado: (2014) -
Induction of Protective Immune Responses Against Schistosomiasis haematobium in Hamsters and Mice Using Cysteine Peptidase-Based Vaccine
por: Tallima, Hatem, et al.
Publicado: (2015) -
Arachidonic Acid Is a Safe and Efficacious Schistosomicide, and an Endoschistosomicide in Natural and Experimental Infections, and Cysteine Peptidase Vaccinated Hosts
por: Tallima, Hatem, et al.
Publicado: (2020) -
Increased hepatic interleukin-1, arachidonic acid, and reactive oxygen species mediate the protective potential of peptides shared by gut cysteine peptidases against Schistosoma mansoni infection in mice
por: Tallima, Hatem, et al.
Publicado: (2023) -
Specific Antibodies and Arachidonic Acid Mediate the Protection Induced by the Schistosoma mansoni Cysteine Peptidase-Based Vaccine in Mice
por: Tallima, Hatem, et al.
Publicado: (2020)